IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Primary Peritoneal Carcinoma
Related studies linked through entity extraction aliases.
Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Status
- RECRUITING
- Phase
- PHASE2
Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment
- Status
- COMPLETED
- Phase
- N/A
Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Surgery for Relapsed Ovarian Cancer in Precision
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Diet, Hepcidin, and Chemotherapy RDI
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- Status
- RECRUITING
- Phase
- PHASE1
RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression
- Status
- RECRUITING
- Phase
- PHASE2
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
- Status
- COMPLETED
- Phase
- N/A
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Sovilnesib in Subjects With Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Biomarker Screening Protocol for Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1